Pliant Therapeutics

Nasdaq:  PLRX

Filing Date:  05/11/20

Launch Date:  05/26/20

Price Range:  $14.00 - $16.00

Shares Offered (Pre-Shoe, mm):  6.0

Primary Shares (mm):  6.0

Secondary Shares (mm):  0.0

Amount Offered (@ Midpoint)(mm):  $90.0

% Secondary:  0.0%

Shares Outstanding (mm):  31.2

Market Value at IPO Midpoint (mm):  $468.6

Offering as % of Market Value:  19.2%

Bookrunners:  Citi | Cowen | Piper Sandler

Co-Manager:  Needham

Major Holders:  Third Rock Ventures | Eventide Asset Management | Redmile Group | Cowen Healthcare Investments | Novartis

Description:  Pliant Therapeutics is a clinical stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis.

Note:  Existing shareholder, Novartis has agreed to a purchase $10mm worth of stock at the IPO price in a concurrent private placement | Emerging Growth Company

Reference Link:  S-1/A